Article info

Download PDFPDF
Effect of rosiglitazone on circulating malondialdehyde (MDA) level in diabetes based on a systematic review and meta-analysis of eight clinical trials

Authors

  1. Correspondence to Dr Mehdi Koushki, Zanjan, Iran (the Islamic Republic of); mehdikoushki89{at}gmail.com
View Full Text

Citation

Majidi Z, Hosseinkhani S, Amiri-Dashatan N, et al
Effect of rosiglitazone on circulating malondialdehyde (MDA) level in diabetes based on a systematic review and meta-analysis of eight clinical trials

Publication history

  • Accepted November 24, 2020
  • First published December 22, 2020.
Online issue publication 
March 04, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.